SUN PHARMACEUTICAL IND LMis à jour SUNPHARMA-Trendline Break.
SUNPHARMA Observations:
-----> Bears Exhaustion gap at support is observed.
------> Bulls taken the control again.
------->Trendline broken, retest is needed to be bullish again.
-------->Expected to be bullish again. If breaks 955-940 zone below will go for selling. Further price action is to be observe before short.
-----> Bears Exhaustion gap at support is observed.
------> Bulls taken the control again.
------->Trendline broken, retest is needed to be bullish again.
-------->Expected to be bullish again. If breaks 955-940 zone below will go for selling. Further price action is to be observe before short.
Note
IT is near to demand zone.. Look for buy 
**If these ideas are Helpful !
Please Like, Follow and Comment
Also share your thoughts in the comments section.
Thanks for your Support **
--Educational Purpose Only--
--Not SEBI Registered--
Please Like, Follow and Comment
Also share your thoughts in the comments section.
Thanks for your Support **
--Educational Purpose Only--
--Not SEBI Registered--
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
**If these ideas are Helpful !
Please Like, Follow and Comment
Also share your thoughts in the comments section.
Thanks for your Support **
--Educational Purpose Only--
--Not SEBI Registered--
Please Like, Follow and Comment
Also share your thoughts in the comments section.
Thanks for your Support **
--Educational Purpose Only--
--Not SEBI Registered--
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.